U.K., Belgium Among Nations Seeking Cheaper India-Made Vaccines
- New Delhi has started shipping doses to South Asian nations
- India can raise capacity to export 500 million doses
The Covishield vaccine, developed by AstraZeneca and the University of Oxford and manufactured by Serum Institute of India.
Photographer: Dhiraj Singh/BloombergIndia says it can increase its production of Covid-19 vaccines to 500 million per month for export, as it fields interest from the U.K., Belgium, and countries across the Middle East and Africa seeking access to cheaper inoculations.
The South Asian nation has the capacity to boost the production of AstraZeneca Plc’s vaccine being produced locally by the Serum Institute of India Ltd as well as an indigenously developed shot, on expectations that demand will rise by the end of this week, according to people with knowledge of the matter, who asked not to be identified as talks are still in progress. South Africa, Kenya and Nigeria are among African nations in talks for supplies, they said.